drugset / Trial / NCT00166686
Clonidine for Neurocognitive Sequelae
Phase 1/2
Withdrawn
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
RandomizedCrossoverDouble-blindTreatment
Summary
The goals of the study are to determine the efficacy of clonidine in the treatment of children with neurocognitive sequelae following the therapy of long term malignancies. In addition, the study hopes to determine the long-term effect of clonidine on children's academic and psychosocial function.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clonidine | Other / unclassified | — | — |